vs
Side-by-side financial comparison of STANDARD BIOTOOLS INC. (LAB) and PARK AEROSPACE CORP (PKE). Click either name above to swap in a different company.
STANDARD BIOTOOLS INC. is the larger business by last-quarter revenue ($19.6M vs $17.3M, roughly 1.1× PARK AEROSPACE CORP). PARK AEROSPACE CORP runs the higher net margin — 17.0% vs -177.4%, a 194.4% gap on every dollar of revenue. On growth, PARK AEROSPACE CORP posted the faster year-over-year revenue change (20.3% vs -11.5%). PARK AEROSPACE CORP produced more free cash flow last quarter ($4.3M vs $-23.1M). Over the past eight quarters, PARK AEROSPACE CORP's revenue compounded faster (3.0% CAGR vs -12.2%).
Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
Park Electrochemical Corp, now called the Park Aerospace Corp, is a Melville, New York-based materials manufacturer for the telecommunications, Internet infrastructure, high-end computing, and aerospace industries. It produces high-technology digital and radio frequency(RF)/microwave printed circuit material products, composite materials. Its printed circuit materials are used for complex multilayer printed circuit boards and other electronic interconnection systems, such as multilayer back-p...
LAB vs PKE — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.6M | $17.3M |
| Net Profit | $-34.7M | $3.0M |
| Gross Margin | 48.5% | 34.1% |
| Operating Margin | -168.5% | 21.0% |
| Net Margin | -177.4% | 17.0% |
| Revenue YoY | -11.5% | 20.3% |
| Net Profit YoY | -28.8% | 87.1% |
| EPS (diluted) | $-0.09 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $17.3M | ||
| Q3 25 | $19.6M | $16.4M | ||
| Q2 25 | $21.8M | $15.4M | ||
| Q1 25 | $40.8M | $16.9M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | $22.1M | $16.7M | ||
| Q2 24 | $22.5M | $14.0M | ||
| Q1 24 | $45.5M | $16.3M |
| Q4 25 | — | $3.0M | ||
| Q3 25 | $-34.7M | $2.4M | ||
| Q2 25 | $-33.5M | $2.1M | ||
| Q1 25 | $-26.0M | $1.2M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | $-26.9M | $2.1M | ||
| Q2 24 | $-45.7M | $993.0K | ||
| Q1 24 | $-32.2M | $2.7M |
| Q4 25 | — | 34.1% | ||
| Q3 25 | 48.5% | 31.2% | ||
| Q2 25 | 48.8% | 30.6% | ||
| Q1 25 | 48.4% | 29.3% | ||
| Q4 24 | — | 26.6% | ||
| Q3 24 | 54.9% | 28.5% | ||
| Q2 24 | 46.1% | 29.3% | ||
| Q1 24 | 53.1% | 27.3% |
| Q4 25 | — | 21.0% | ||
| Q3 25 | -168.5% | 17.4% | ||
| Q2 25 | -118.1% | 15.7% | ||
| Q1 25 | -80.8% | 16.8% | ||
| Q4 24 | — | 12.8% | ||
| Q3 24 | -120.9% | 15.7% | ||
| Q2 24 | -134.5% | 14.9% | ||
| Q1 24 | -132.2% | 15.7% |
| Q4 25 | — | 17.0% | ||
| Q3 25 | -177.4% | 14.7% | ||
| Q2 25 | -153.7% | 13.5% | ||
| Q1 25 | -63.8% | 7.4% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | -122.0% | 12.4% | ||
| Q2 24 | -203.3% | 7.1% | ||
| Q1 24 | -70.6% | 16.3% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | $-0.09 | $0.12 | ||
| Q2 25 | $-0.09 | $0.10 | ||
| Q1 25 | $-0.07 | $0.06 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | $-0.07 | $0.10 | ||
| Q2 24 | $-0.12 | $0.05 | ||
| Q1 24 | $-0.27 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $129.4M | $63.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $399.7M | $106.6M |
| Total Assets | $539.6M | $118.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $63.6M | ||
| Q3 25 | $129.4M | $61.6M | ||
| Q2 25 | $158.6M | $65.6M | ||
| Q1 25 | $150.9M | $68.8M | ||
| Q4 24 | — | $70.0M | ||
| Q3 24 | $210.6M | $72.0M | ||
| Q2 24 | $269.8M | $74.4M | ||
| Q1 24 | $287.1M | $77.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $106.6M | ||
| Q3 25 | $399.7M | $105.8M | ||
| Q2 25 | $424.5M | $105.0M | ||
| Q1 25 | $454.6M | $107.2M | ||
| Q4 24 | — | $107.4M | ||
| Q3 24 | $489.3M | $110.3M | ||
| Q2 24 | $510.3M | $111.7M | ||
| Q1 24 | $577.3M | $112.9M |
| Q4 25 | — | $118.1M | ||
| Q3 25 | $539.6M | $116.4M | ||
| Q2 25 | $557.0M | $120.7M | ||
| Q1 25 | $579.6M | $122.1M | ||
| Q4 24 | — | $124.2M | ||
| Q3 24 | $681.5M | $125.1M | ||
| Q2 24 | $708.7M | $129.4M | ||
| Q1 24 | $777.7M | $132.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.2M | $5.1M |
| Free Cash FlowOCF − Capex | $-23.1M | $4.3M |
| FCF MarginFCF / Revenue | -118.1% | 24.6% |
| Capex IntensityCapex / Revenue | 4.5% | 4.8% |
| Cash ConversionOCF / Net Profit | — | 1.73× |
| TTM Free Cash FlowTrailing 4 quarters | $-111.1M | $3.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.1M | ||
| Q3 25 | $-22.2M | $-2.1M | ||
| Q2 25 | $-20.7M | $1.6M | ||
| Q1 25 | $-30.3M | $969.0K | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | $-27.9M | $1.4M | ||
| Q2 24 | $-39.0M | $-423.0K | ||
| Q1 24 | $-62.5M | $5.3M |
| Q4 25 | — | $4.3M | ||
| Q3 25 | $-23.1M | $-2.3M | ||
| Q2 25 | $-22.6M | $1.1M | ||
| Q1 25 | $-35.3M | $338.0K | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | $-30.1M | $1.3M | ||
| Q2 24 | $-41.0M | $-435.0K | ||
| Q1 24 | $-63.3M | $5.1M |
| Q4 25 | — | 24.6% | ||
| Q3 25 | -118.1% | -14.0% | ||
| Q2 25 | -103.6% | 7.2% | ||
| Q1 25 | -86.6% | 2.0% | ||
| Q4 24 | — | 18.6% | ||
| Q3 24 | -136.4% | 7.5% | ||
| Q2 24 | -182.2% | -3.1% | ||
| Q1 24 | -138.9% | 31.4% |
| Q4 25 | — | 4.8% | ||
| Q3 25 | 4.5% | 1.1% | ||
| Q2 25 | 8.7% | 3.1% | ||
| Q1 25 | 12.4% | 3.7% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | 10.2% | 1.2% | ||
| Q2 24 | 8.6% | 0.1% | ||
| Q1 24 | 1.7% | 1.0% |
| Q4 25 | — | 1.73× | ||
| Q3 25 | — | -0.88× | ||
| Q2 25 | — | 0.76× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 1.73× | ||
| Q3 24 | — | 0.70× | ||
| Q2 24 | — | -0.43× | ||
| Q1 24 | — | 1.98× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
PKE
| North America | $16.8M | 97% |
| Other | $546.0K | 3% |
